Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04324021
What this trial is testing

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.

Who this might be right for
SARS-CoV-2
Swedish Orphan Biovitrum 16
Testing effectiveness (Phase 2)UnknownNCT04805086
What this trial is testing

The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseCovid19
Guy's and St Thomas' NHS Foundation Trust 5
Not applicableUnknownNCT04716985
What this trial is testing

Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care

Who this might be right for
SARS-CoV-2Covid19AMBULATORY CARE
AGIR à Dom 700
Testing effectiveness (Phase 2)Study completedNCT04610502
What this trial is testing

Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients

Who this might be right for
Covid19
Caja Costarricense de Seguro Social 26
Large-scale testing (Phase 3)UnknownNCT04535869
What this trial is testing

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)

Who this might be right for
COVID-19
Mansoura University 50
Post-approval studies (Phase 4)UnknownNCT04445935
What this trial is testing

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Who this might be right for
Anticoagulation in COVID-19 ARDS
Hamad Medical Corporation 100
Early research (Phase 1)Study completedNCT04483375
What this trial is testing

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Who this might be right for
Coronavirus Disease 2019(COVID-19)
Sinocelltech Ltd. 33
Large-scale testing (Phase 3)Ended earlyNCT04581915
What this trial is testing

PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19

Who this might be right for
Covid19
Wits Health Consortium (Pty) Ltd 74
Not applicableUnknownNCT04852835
What this trial is testing

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Who this might be right for
COVID-19 Vaccines
University Hospital, Strasbourg, France 800
Large-scale testing (Phase 3)Study completedNCT04655586
What this trial is testing

Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19

Who this might be right for
Covid19
ARCA Biopharma, Inc. 160
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Testing effectiveness (Phase 2)UnknownNCT04356508
What this trial is testing

COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1

Who this might be right for
COVID-19SARS-CoV-22019-nCoV+1 more
Dr Gerry Gin Wai Kwok 15
Large-scale testing (Phase 3)WithdrawnNCT04853927
What this trial is testing

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
Applied Biology, Inc.
Not applicableStudy completedNCT04816084
What this trial is testing

SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes

Who this might be right for
Covid19
Université de Reims Champagne-Ardenne 389
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Post-approval studies (Phase 4)Study completedNCT05049213
What this trial is testing

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19

Who this might be right for
Covid19SARS-CoV 2 Infection
National Taiwan University Hospital 7
Not applicableStudy completedNCT04534790
What this trial is testing

Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Instituto Mexicano del Seguro Social 30
Early research (Phase 1)UnknownNCT04441918
What this trial is testing

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

Who this might be right for
COVID-19; and High Infection Risk of SARS-CoV-2
Shanghai Junshi Bioscience Co., Ltd. 40
Large-scale testing (Phase 3)Looking for participantsNCT07013474
What this trial is testing

Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Who this might be right for
COVID-19 Infection
Pfizer 300
Not applicableStudy completedNCT04979871
What this trial is testing

SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19

Who this might be right for
Vaccine Reaction
University of Zurich 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation